Sunday, June 08, 2025 8:34:22 AM
StockFollower, please don't walk away from posting just because AI made a mistake when you used it. We've all made mistakes (even without the assistance of AI!). And sometimes we've talked about an issue for days before discovering that we all went down the wrong rabbit hole together, before finally figuring everything out. That's how we, as a board, discover truths we might not have learned.
What I love about this board is we have so many experts here from so many areas who are willing to share their knowledge with us. Particularly when they see us going down the wrong rabbit hole! And I thank them for that. Hyperopia is one of our best and I always read his posts for better clarity on a subject, even, and maybe especially, when he corrects me.
But we also need people like you and me who read, ask questions, and who sometimes put two and two together to get 5 or more because the synergy of ideas puts our stream-of-thought on a whole new level. I did that once before when I noticed our new SAP had OS for rGBM among the new endpoints announced, something that hadn't been in the original. "Doesn't that mean we're pursuing rGBM approval for this trial now, not just nGBM?" I asked the board. And here we are.
BTW, Patents are very difficult, repetitive, boring, and time-consuming to read, so I appreciate you trying to address it with AI. I did some cursory reading but haven't found time to read it thoroughly. But I did read about the rotating arms that shake the ingredients that seemed very different from our current EDEN. I'm very much looking forward to hearing from the company what they expect the improved EDEN to do.
What I love about this board is we have so many experts here from so many areas who are willing to share their knowledge with us. Particularly when they see us going down the wrong rabbit hole! And I thank them for that. Hyperopia is one of our best and I always read his posts for better clarity on a subject, even, and maybe especially, when he corrects me.
But we also need people like you and me who read, ask questions, and who sometimes put two and two together to get 5 or more because the synergy of ideas puts our stream-of-thought on a whole new level. I did that once before when I noticed our new SAP had OS for rGBM among the new endpoints announced, something that hadn't been in the original. "Doesn't that mean we're pursuing rGBM approval for this trial now, not just nGBM?" I asked the board. And here we are.
BTW, Patents are very difficult, repetitive, boring, and time-consuming to read, so I appreciate you trying to address it with AI. I did some cursory reading but haven't found time to read it thoroughly. But I did read about the rotating arms that shake the ingredients that seemed very different from our current EDEN. I'm very much looking forward to hearing from the company what they expect the improved EDEN to do.
Bullish
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
